Clinical trial
Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or…
NCT00003585 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00003585 |
|---|---|
| Title | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer |
| Official title | A Phase I/II Pilot Study of a Novel Four Drug Regimen for the Treatment of Advanced Renal Cell Carcinoma: FUNIL-cRA |
| Lead sponsor | University of New Mexico, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | aldesleukin, recombinant interferon alfa, fluorouracil, isotretinoin, surgical procedure |
| Enrollment | 35 |
| Start date | Aug 1, 1996 |
| Primary completion | Aug 1, 2001 |
| Completion | Aug 1, 2002 |
| First posted | Jul 22, 2004 |
| Last update posted | Dec 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: